2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.50-$0.005 (-0.14%)
Price as of Aug 21, 2026 7:59 PM EDT- $1.9BMarket Cap
- -29.15%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.50-$0.005 (-0.14%)
RXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.50 | ||
Change | +$0.16 (+4.79%) | ||
Open | $3.39 | ||
High | $3.63 | ||
Low | $3.37 | ||
Previous Close | $3.34 | ||
Volume | 22,898,467 | ||
30-Day Average Volume | 16,367,334 | ||
1-Week Change | 10.76% | ||
1-Month Change | 13.64% | ||
1-Year Change | -29.15% | ||
3-Year Change | -60.41% | ||
5-Year Change | -82.37% | ||
Fundamentals | |||
Shares Outstanding | 535.3M | ||
Total Assets | $1.2B | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $7.3M | ||
Net Income | -$131.0M | ||
Free Cash Flow | -$106.0M | ||
EBIT | -$131.0M | ||
EBITDA | -$112.8M | ||
Net Working Capital | $483.6M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 184 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | 1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue